Background
Asthma is a common chronic inflammatory disease characterized by airway inflammation, airway hyperresponsiveness, mucus hyperproduction, and airway remodeling [
1]. The Th2 cells and the cytokines that typify the Th2 cell subset underlies the inappropriate immune responses that characterize allergic asthma [
2]. The “signature” cytokines of Th2 cells, interleukin (IL)-4, IL-5 and IL-13, have a central role in infiltration of eosinophils and increased secretion of mucus [
3,
4].
Serine protease inhibitors (SERPINS) are a superfamily of homologous proteins that have important roles in inflammation, immune-system function, apoptosis regulation [
5,
6], and metastasis of cancer cells [
7]. Human SERPINS are divided into nine groups (A–I) called “clades” according to their sequence similarity. Expression of several members in clade B, such as SERPINB2, SERPINB3 and SERPINB4, is upregulated in allergic diseases, and they modulate Th1/Th2 responses [
8‐
10]. Mice with SERPINB2 deficiency have a defective response from Th2 cytokines after nematode infection [
8]. SERPINB3 and SERPINB4 in patients suffering from allergic disease control the viability of Th2 cells by exerting anti-apoptotic effects [
11].
SERPINB10 is another member of clade B. Previously, we reported that SERPINB10 expression was increased in the bronchial epithelial cells of patients with asthma and was associated with airway eosinophilic inflammation. Knockdown of SERPINB10 expression can reduce airway hyperresponsiveness and airway eosinophilic inflammation in a murine model of asthma [
12]. The role of SERPINB10 in the Th2 response of allergic asthma is not known. Schleef and colleagues reported that SERPINB10 can inhibit tumor necrosis factor α (TNF-α)-induced cell death [
13]. Therefore, we hypothesized that SERPINB10 may participate in the Th2 response of allergic asthma by affecting the apoptosis of Th2 cells.
We investigated the effect of knockdown of SERPINB10 expression on the Th2 response and apoptosis of Th cells in a house dust mite (HDM)-induced model of asthma. We measured expression of SERPINB10 in polarized Th1 and Th2 cells derived from patients with asthma. We assessed the effect of SERPINB10 on the apoptosis of Th cells in vitro.
Methods
Mouse model
Female C57BL/6 J mice (6–8 weeks) were purchased from JSJ Laboratory (Shanghai, China) and bred under specific pathogen-free conditions at the animal center of Zhongshan Hospital, Fudan University (Shanghai, China). All experimental protocols were approved by the Animal Care and Use Committee of Zhongshan Hospital. Mice were anesthetized with isoflurane and administered, via the intratracheal route, adeno-associated virus (AAV) (30 µL; 6.32 × 1012 viral particles/mL; Vigene Biosciences, Shandong, China) containing SERPINB10 short hairpin (sh)RNA or scrambled shRNA. The sequence of SERPINB10 shRNA was GCAGAACCACAATCTGTTAACTTCAAGAGAGTTAACAGATTGTGGTTCTGCTTTTTT. After 2 weeks, the mice were sacrificed to evaluate the knockdown efficiency of Serpinb10 AAV. Another batch of mice was used to establish an HDM asthma model. Mice were randomly divided into three groups: control group, asthma group and knockdown asthma group. Mice were sensitized by intranasal instillation of HDM extract (10 μg; Greer Laboratories, Lenoir, NC, USA) in 40 μL of phosphate-buffered saline (PBS) on days 0, 1, and 2. From day-8 to day-12, mice were challenged daily by intranasal administration of HDM (10 μg in 40 μL of PBS). Control mice were given, via the intranasal route, 40 μL of PBS during sensitization and challenge phases. Two weeks before the first sensitization, mice were administered 30 µL AAV containing SERPINB10 shRNA or scrambled shRNA. Mice were sacrificed for evaluation on day-14. There were five to six mice per group for each independent experiment.
RT-qPCR and Western blotting
RT-qPCR and Western blotting were performed as our previous study [
12] and the protocol is given in the Additional file
2: Materials and Methods. The primer sequences of all genes for PCR are listed in Additional file
1: Table S1.
Analyses of bronchoalveolar lavage fluid (BALF)
BALF was collected according to a method described previously [
14]. Briefly, the trachea was cannulated through a 22-inch intravenous catheter and the lungs were lavaged with a total volume of 1 mL PBS for three successive aspirations to obtain BALF. The BALF was centrifuged at 500×
g for 8 min at 4 ℃. The cell-free supernatant was collected for cytokine analyses using ELISA kits. Cell pellets were resuspended in PBS and the total cell number was counted using CellDrop® (DeNovix, Wilmington, DE, USA). Cells were analyzed by flow cytometry using PE-conjugated anti-SiglecF (eBioscience, San Diego, CA, USA), FITC-conjugated anti-CD3 (BD Biosciences, San Jose, CA, USA), APC-conjugated anti-CD11c (Multiscience, Zhejiang, China), FITC-conjugated anti-CD19 (BioLegend, San Diego, CA, USA), Percp-cy5.5-conjugated anti-Ly6G (BioLegend) and PE-cy7-conjugated anti-MHC II (BioLegend). The flow cytometry gating strategy was according to a method described previously [
15].
Flow cytometry of lung tissues
We wished to calculate the number of Th cells in lungs. Lung tissues were immersed in Hank’s medium containing collagenase IV (1 mg/mL) and DNase I (20 μg/mL). Lung tissues were ground using a gentleMACS® Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany) and then incubated with shaking at 100 rpm for 30 min at 37 ℃. Digested tissues were filtered through 70-μm nylon mesh, treated with red blood cell lysis buffer, and washed with staining buffer (PBS containing 2% fetal bovine serum). Cells were first incubated with purified anti-mouse CD16/32 (eBioscience) for 10 min (to block Fc receptors) and then stained with a mixture of Percp-cy5.5-conjugated anti-CD3e (BioLegend), BV510-conjugated anti-CD4 (BD Bioscience) and APC-cy7-conjugated anti-CD45 (BioLegend) for 30 min on ice. For intracellular staining, cells were fixed and permeabilized with Transcription Factor Buffer Set (BD Pharmingen, Franklin Lakes, NJ, USA) before addition of AF647-conjugated anti-GATA3 (BioLegend), BV421-conjugated anti- T-bet (BD Pharmingen) and PE-conjugated anti-active caspase-3 (BD Pharmingen). After washing, samples were analyzed by an Arial III flow cytometer (BD Biosciences) and data were analyzed using FlowJo® (Tree Star, Ashland, OR, USA).
Histology
The left lobes of mouse lungs were perfused with 0.3 ml 4% paraformaldehyde and then the left lobes of mouse lungs were isolated and fixed in 4% paraformaldehyde. Paraffin-embedded 5-μm lung sections were stained with hematoxylin and eosin (H&E) and periodic acid Schiff to assess infiltration of inflammatory cells, goblet-cell metaplasia, and mucus production.
Measurement of levels of HDM-specific IgE and cytokines
Mouse ELISA kits for IL-4, IL-5 and IL-13 in BALF (R&D Systems, Minneapolis, MN, USA) and HDM-specific IgE in serum (JingKang Biotech, Shanghai, China) were used to measure protein expression according to manufacturer instructions. The cytokines in supernatants produced by polarized T cells were stained using the LEGENDplex® panel for human Th cytokines (BioLegend) and measured by flow cytometry.
Clinical samples
Patients with asthma were diagnosed by a physician according to Global Initiative for Asthma guidelines. All asthma patients were clinically diagnosed with symptomatic asthma and demonstrated evidence of a hyperresponsive airway (provocative dose of methacholine causing a 20% drop in FEV1 < 2.5 mg) and/or bronchodilator responsiveness (> 12% improvement in FEV1% predicted following inhalation of 200 μg of salbutamol). None of the patients had ever received inhaled or oral corticosteroid or leukotriene antagonist. Demographic information (Table
1) and blood samples from 16 patients were collected for study. Written informed consent was obtained from all patients. This study was approved by the ethics committee of Zhongshan hospital, Fudan University.
Table 1
Subject characteristics
Age, year | 35 (18,66) |
Sex, M:F | 6:10 |
Body mass index | 23.8 ± 3.6 |
FEV1, % predict | 90.6 ± 13.6 |
FENO, ppb | 40.5 (16.25, 88.25) |
Total IgE, IU/ml | 254.0 (231.3, 340.5) |
Polarization of Th1 and Th2 cells in vitro
Heparinized venous blood was collected from patients with asthma. Then, it was diluted (1:1) with PBS and layered on Lymphoprep® (StemCell Technologies, Vancouver, Canada) density-gradient medium and centrifuged for 20 min at 800×g at room temperature. The layer of peripheral-blood mononuclear cells was collected, washed and resuspended in RoboSep® Buffer (StemCell Technologies). Naïve CD4+CD45RA+CD45RO− T cells were negatively selected and enriched using EasySep® Human Naïve CD4+ T Cell Isolation Kit II (StemCell Technologies) according to manufacturer instructions. The purity of the final isolated fraction (as determined by flow cytometry using FITC-conjugated anti-CD4, PE conjugated anti-CD45RA and APC-conjugated anti-CD45RO (BioLegend)) was 97%. Purified naïve CD4+ T cells were cultured in ImmunoCult®-XF Cell Expansion Medium (StemCell Technologies) and stimulated with plate-bound anti-CD3 (2 μg/mL) and anti-CD28 (4 μg/mL; Peprotech-BioGems, Westlake Village, CA, USA). ImmunoCult Human Th1 Differentiation Supplement (StemCell Technologies) and ImmunoCult Human Th2 Differentiation Supplement (StemCell Technologies) were added to direct the differentiation of Th1 and Th2 cells, respectively. After 3–4 days, cells were expanded under identical conditions in the absence of anti-CD3 and anti-CD28. Then, cells were re-stimulated every 7 days. If required, cells were activated with Leukocyte Activation Cocktail (BD Pharmingen) for 6 h.
Knockdown of SERPINB10 expression in T cells
Lentivirus containing SERPINB10 shRNA or scrambled shRNA were used to transduce CD4+ T cells. The sequence of SERPINB10 shRNA was GCCTGTTAACTTTGTGGAA. Naïve CD4+CD45RA+CD45RO− T cells were stimulated with plate-bound anti-CD3 and anti-CD28. After 48 h, they were transduced with lentivirus (multiplicity of infection = 100) by centrifugation at 500×g for 90 min at room temperature in polybrene (6 μg/mL) and then cultured at 37℃ in a chamber containing 5% CO2. After 3 days, cells were analyzed by flow cytometry for expression of CD4 and green fluorescent protein (GFP). If required, GFP+ cells were sorted by flow cytometry and cultured under polarization conditions.
Statistical analyses
Data are the mean ± SEM and were analyzed using Prism 8 (Graph Pad, San Diego, CA, USA). Differences were assessed using the unpaired Student’s t-test between two groups, and one-way analysis of variance with Tukey’s multiple comparison test among three groups. P < 0.05 was considered significant.
Discussion
We demonstrated that knockdown of SERPINB10 expression alleviated allergic inflammation and Th2 responses in an HDM model of asthma. SERPINB10-knockdown mice had diminished numbers of Th2 cells and greater apoptosis after HDM challenge. SERPINB10 was expressed in polarized Th2 cells from patients with asthma. SERPINB10 expression was upregulated in polarized Th2, but not Th1, cells after TCR stimulation. Knockdown of SERPINB10 expression in human polarized Th cells resulted in significant impairment of survival of Th2 cells. Our results indicate that SERPINB10 contributes to the survival of Th2 cells in mice and humans.
One genome-wide association study found that many
cis-expression quantitative trait loci across SERPINB10 were in the chromatin-interaction regions of transcriptional/enhancer activity in some immune cells. Those findings indicate that SERPINB10 has central roles in the immune response [
17]. A review by Ashton and colleagues showed that several SERPINS in clade B can control the recognition of antigens and effector functions of T lymphocytes by promoting their viability [
18].
Here we showed, for the first time, that SERPINB10 has a protective effect upon Th2 cells in people with asthma and in mice challenged by HDM. The role of SERPINB10 in Th2 cells was significantly different from its role in other T cells. In the present study, there was no evidence that SERPINB10 had an effect on the survival of Th1 cells. However the use of a more physiological relavant model for in vivo Th1 development than HDM model would be useful to more fully explore this possibility. We speculate that the specific anti-apoptotic effect of SERPINB10 upon Th2 cells was due to upregulation of SERPINB10 expression through TCR stimulation, whereas SERPINB10 expression in Th1 cells was not upregulated after stimulation and, therefore, Th1 cells were not affected. However, the mechanism by which TCR signals upregulate SERPINB10 expression in Th2 cells, but not in Th1 cells, merits further study.
One in vitro polarization study demonstrated that Th2 cells are relatively resistant to activation-induced cell death compared with Th1 cells [
19]. We found that, compared with Th2 cells, more Th1 cells suffered apoptosis. Our data clearly show that SERPINB10 protects Th2 cells, but not Th1 cells, from apoptosis. Our findings suggest that SERPINB10 may promote allergic asthma by inhibiting the apoptosis of Th2 cells.
The persistence of Th2 cells and increased apoptosis of Th1 cells contributes to atopic and allergic diseases [
20‐
22]. Eliminating Th2 cells by inducing apoptosis may help to alleviate allergic asthma [
23,
24]. We showed that targeting of SERPINB10 expression by shRNA significantly decreased the number of Th2 cells in mouse lungs, and promoted the apoptosis of Th2 cells in patients suffering from asthma. Krug and coworkers found that cleaved and inactive GATA-3 mRNA can attenuate the asthmatic response and Th2-regulated inflammatory response in patients with allergic asthma [
25]. Taken together, these findings provide support for the concept of targeting Th2 cells by knockdown of SERPINB10 expression.
Our study had three main limitations. First, in vivo data were based on knockdown of SERPINB10 expression in mouse lungs, but not in SERPINB10-knockout mice. Second, we sorted naïve CD4 T cells from the peripheral blood of asthma patients and explore the expression and the role of SERPINB10 in Th1 and Th2 cells. The role of SERPINB10 in helper T cells of healthy subjects still needs to be further clarified. Third, Th2 cytokines such as IL-4, IL-5 and IL-13 can also be secreted by group-2 innate lymphoid (ILC2) cells, which are activated at an early stage of sensitization and promote innate allergic inflammation and the adaptive Th2 response [
26,
27]. Further studies will clarify if SERPINB10 protects ILC2 cells from apoptosis in allergic asthma.
Conclusions
We demonstrated, for the first time, that SERPINB10 protects Th2 cells from apoptosis. SERPINB10 may represent a therapeutic target for alleviation of the Th2 response in asthma.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.